T. Rowe Price Health Sciences Fund (PRHSX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
73.45
+0.75 (1.03%)
May 15, 2025, 8:04 PM EDT
PRHSX Holdings List
As of Mar 31, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | LLY | Eli Lilly and Company | 10.71% |
2 | n/a | Aggregate Miscellaneous Equity | 8.83% |
3 | UNH | UnitedHealth Group Incorporated | 7.31% |
4 | ISRG | Intuitive Surgical, Inc. | 4.92% |
5 | SYK | Stryker Corporation | 4.45% |
6 | TMO | Thermo Fisher Scientific Inc. | 3.94% |
7 | ARGX | argenx SE | 3.54% |
8 | VRTX | Vertex Pharmaceuticals Incorporated | 3.27% |
9 | BSX | Boston Scientific Corporation | 3.13% |
10 | DHR | Danaher Corporation | 3.07% |
11 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.51% |
12 | ELV | Elevance Health, Inc. | 2.20% |
13 | AZN | AstraZeneca PLC | 1.90% |
14 | CI | The Cigna Group | 1.85% |
15 | INSM | Insmed Incorporated | 1.60% |
16 | MRK | Merck & Co., Inc. | 1.60% |
17 | REGN | Regeneron Pharmaceuticals, Inc. | 1.56% |
18 | AMGN | Amgen Inc. | 1.51% |
19 | ONC | BeiGene, Ltd. | 1.51% |
20 | GILD | Gilead Sciences, Inc. | 1.45% |
21 | SNY | Sanofi | 1.21% |
22 | ASND | Ascendis Pharma A/S | 1.20% |
23 | PEN | Penumbra, Inc. | 1.18% |
24 | BPMC | Blueprint Medicines Corporation | 1.10% |
25 | HCA | HCA Healthcare, Inc. | 0.90% |
26 | TRPGRIA | T. Rowe Price Gov. Reserve | 0.76% |
27 | MOH | Molina Healthcare, Inc. | 0.72% |
28 | BDX | Becton, Dickinson and Company | 0.72% |
29 | VRNA | Verona Pharma plc | 0.70% |
30 | THC | Tenet Healthcare Corporation | 0.69% |
31 | TYO: 4519 | Chugai Pharmaceutical Co., Ltd. | 0.67% |
32 | NTRA | Natera, Inc. | 0.64% |
33 | RNA | Avidity Biosciences, Inc. | 0.58% |
34 | NBIX | Neurocrine Biosciences, Inc. | 0.54% |
35 | SRRK | Scholar Rock Holding Corporation | 0.53% |
36 | IDXX | IDEXX Laboratories, Inc. | 0.52% |
37 | ZLAB | Zai Lab Limited | 0.52% |
38 | MCK | McKesson Corporation | 0.51% |
39 | COR | Cencora, Inc. | 0.49% |
40 | DGX | Quest Diagnostics Incorporated | 0.49% |
41 | RVMD | Revolution Medicines, Inc. | 0.46% |
42 | CAH | Cardinal Health, Inc. | 0.46% |
43 | n/a | Sonova Holding AG | 0.44% |
44 | CVS | CVS Health Corporation | 0.41% |
45 | AKRO | Akero Therapeutics, Inc. | 0.41% |
46 | MLTX | MoonLake Immunotherapeutics | 0.41% |
47 | PTGX | Protagonist Therapeutics, Inc. | 0.39% |
48 | CNTA | Centessa Pharmaceuticals plc | 0.39% |
49 | ACLX | Arcellx, Inc. | 0.38% |
50 | EXAS | Exact Sciences Corporation | 0.37% |
51 | RVTY | Revvity, Inc. | 0.36% |
52 | MDGL | Madrigal Pharmaceuticals, Inc. | 0.35% |
53 | ALKS | Alkermes plc | 0.33% |
54 | PCVX | Vaxcyte, Inc. | 0.31% |
55 | KRYS | Krystal Biotech, Inc. | 0.30% |
56 | VEEV | Veeva Systems Inc. | 0.29% |
57 | TECH | Bio-Techne Corporation | 0.28% |
58 | BTSG | BrightSpring Health Services, Inc. | 0.28% |
59 | UTHR | United Therapeutics Corporation | 0.28% |
60 | KYMR | Kymera Therapeutics, Inc. | 0.27% |
61 | BHVN | Biohaven Ltd. | 0.27% |
62 | RGEN | Repligen Corporation | 0.26% |
63 | RARE | Ultragenyx Pharmaceutical Inc. | 0.26% |
64 | SLNO | Soleno Therapeutics, Inc. | 0.26% |
65 | OSCR | Oscar Health, Inc. | 0.26% |
66 | AGIO | Agios Pharmaceuticals, Inc. | 0.25% |
67 | CRNX | Crinetics Pharmaceuticals, Inc. | 0.25% |
68 | MTSR | Metsera, Inc. | 0.25% |
69 | SWTX | SpringWorks Therapeutics, Inc. | 0.25% |
70 | VERA | Vera Therapeutics, Inc. | 0.24% |
71 | PRCT | PROCEPT BioRobotics Corporation | 0.23% |
72 | IMCR | Immunocore Holdings plc | 0.22% |
73 | DNLI | Denali Therapeutics Inc. | 0.21% |
74 | BEAM | Beam Therapeutics Inc. | 0.20% |
75 | DXCM | DexCom, Inc. | 0.18% |
76 | APGE | Apogee Therapeutics, Inc. | 0.18% |
77 | CNC | Centene Corporation | 0.17% |
78 | ETR: SRT3 | Sartorius Aktiengesellschaft | 0.17% |
79 | BIIB | Biogen Inc. | 0.17% |
80 | EHC | Encompass Health Corporation | 0.16% |
81 | LEGN | Legend Biotech Corporation | 0.15% |
82 | REPL | Replimune Group, Inc. | 0.13% |
83 | RYTM | Rhythm Pharmaceuticals, Inc. | 0.13% |
84 | TARS | Tarsus Pharmaceuticals, Inc. | 0.13% |
85 | IMNM | Immunome, Inc. | 0.12% |
86 | IONS | Ionis Pharmaceuticals, Inc. | 0.12% |
87 | LH | Labcorp Holdings Inc. | 0.12% |
88 | MRUS | Merus N.V. | 0.12% |
89 | CYTK | Cytokinetics, Incorporated | 0.12% |
90 | IMCR.2.5 02.01.30 | Immunocore Holdings plc 2.5% | 0.10% |
91 | IRON | Disc Medicine, Inc. | 0.10% |
92 | LNTH | Lantheus Holdings, Inc. | 0.10% |
93 | ICLR | ICON Public Limited Company | 0.10% |
94 | CGON | CG Oncology, Inc. | 0.09% |
95 | HLXB | Helix Acquisition Corp. II | 0.08% |
96 | BCYC | Bicycle Therapeutics plc | 0.08% |
97 | CLDX | Celldex Therapeutics, Inc. | 0.07% |
98 | PRAX | Praxis Precision Medicines, Inc. | 0.07% |
99 | WVE | Wave Life Sciences Ltd. | 0.06% |
100 | PHVS | Pharvaris N.V. | 0.06% |
101 | XNCR | Xencor, Inc. | 0.05% |
102 | RCKT | Rocket Pharmaceuticals, Inc. | 0.05% |
103 | n/a | Kardium Inc | 0.05% |
104 | ORIC | ORIC Pharmaceuticals, Inc. | 0.04% |
105 | SION | Sionna Therapeutics, Inc. | 0.04% |
106 | NVCR | NovoCure Limited | 0.04% |
107 | GLUE | Monte Rosa Therapeutics, Inc. | 0.04% |
108 | PRTA | Prothena Corporation plc | 0.04% |
109 | GPCR | Structure Therapeutics Inc. | 0.04% |
110 | EPA: ALSEN | Sensorion SA | 0.04% |
111 | n/a | Galvanize Therapeutics Inc Cvt | 0.04% |
112 | ALLO | Allogene Therapeutics, Inc. | 0.03% |
113 | n/a | Cash Offsets For Shorts & Derivatives | 0.03% |
114 | SANA | Sana Biotechnology, Inc. | 0.03% |
115 | IDYA | IDEAYA Biosciences, Inc. | 0.02% |
116 | ORKA | Oruka Therapeutics, Inc. | 0.02% |
117 | ARVN | Arvinas, Inc. | 0.02% |
118 | IOVA | Iovance Biotherapeutics, Inc. | 0.02% |
119 | LYEL | Lyell Immunopharma, Inc. | 0.02% |
120 | n/a | Saluda Medical Cvt Prom Note Pp | 0.02% |
121 | TRDA | Entrada Therapeutics, Inc. | 0.02% |
122 | RLAY | Relay Therapeutics, Inc. | 0.02% |
123 | AURA | Aura Biosciences, Inc. | 0.02% |
124 | SYRE | Spyre Therapeutics, Inc. | 0.02% |
125 | CRGX | CARGO Therapeutics, Inc. | 0.02% |
126 | OBIO | Orchestra BioMed Holdings, Inc. | 0.01% |
127 | VYGR | Voyager Therapeutics, Inc. | 0.01% |
128 | ANAB | AnaptysBio, Inc. | 0.01% |
129 | KYTX | Kyverna Therapeutics, Inc. | 0.01% |
130 | n/a | Profoundbio Escrow Fund Payment Pp | 0.01% |
131 | IMRX | Immuneering Corporation | 0.01% |
132 | GBIO | Generation Bio Co. | 0.01% |
133 | PRLD | Prelude Therapeutics Incorporated | 0.00% |
134 | ANNX | Annexon, Inc. | 0.00% |
135 | ALEC | Alector, Inc. | 0.00% |
136 | CABA | Cabaletta Bio, Inc. | 0.00% |
137 | DNA | Ginkgo Bioworks Holdings, Inc. | 0.00% |
138 | WGSWW | GeneDx Holdings Corp. | 0.00% |
139 | n/a | Affinivax | 0.00% |
140 | RVMDW | Revolution Medicines, Inc. | 0.00% |
141 | n/a | Profoundbio Expense Fund Payment Pp | 0.00% |
142 | n/a | Somalogic ([Wts/Rts]) | 0.00% |
As of Mar 31, 2025